Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Bio-Techne Corporation (TECH)

208.53   2.88 (1.4%) 02-14 16:00
Open: 206.16 Pre. Close: 205.65
High: 209 Low: 205.38
Volume: 77,551 Market Cap: 7859M
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 209.194 - 209.999 209.999 - 210.923
Low: 203.176 - 204.046 204.046 - 205.045
Close: 206.903 - 208.307 208.307 - 209.921

Technical analysis

as of: 2020-02-14 4:33:01 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 248.93     One year: 260.80
Support: Support1: 196.67    Support2: 163.63
Resistance: Resistance1: 213.12    Resistance2: 223.29
Pivot: 208.95
Moving Average: MA(5): 206.17     MA(20): 211.46
MA(100): 210.51     MA(250): 204.16
MACD: MACD(12,26): -3.09     Signal(9): -2.78
Stochastic oscillator: %K(14,3): 41.41     %D(3): 37.33
RSI: RSI(14): 44.68
52-week: High: 223.29  Low: 178.28  Change(%): 8.7
Average Vol(K): 3-Month: 14451  10-Days: 21530

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
TECH has closed above bottom band by 47.9%. Bollinger Bands are 47.4% wider than normal. The large width of the bands suggest high volatility as compared to TECH's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

Bio-Techne Announces Availability Of Next Generation ELISA Kits
MINNEAPOLIS, Feb. 5, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global leader and the most cited manufacturer of immunoassay kits, announced the release of the Quantikine QuicKit™ ELISA product line. This next generation ELISA product line expands the capabilities of…

Bio-Techne EPS misses by $0.06, misses on revenue
Bio-Techne (NASDAQ:TECH): Q2 Non-GAAP EPS of $1.08 misses by $0.06; GAAP EPS of $3.02 beats by $2.38. Revenue of $184.93M (+6.0% Y/Y) misses by $6.41M. Pre

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 38.11
Shares Float (M) 37.91
% Held by Insiders 0.49
% Held by Institutions 96.50
Shares Short (K) 475
Shares Short P. Month (K)

Stock Financials

EPS 2.390
Book Value (p.s.) 30.830
PEG Ratio 3.93
Profit Margin 12.68
Operating Margin 21.65
Return on Assets (ttm) 5.2
Return on Equity (ttm) 8.1
Qtrly Rev. Growth 12.4
Gross Profit (p.s.) 12.522
Sales Per Share
EBITDA (p.s.) 5.375
Qtrly Earnings Growth -17.30
Operating Cash Flow (M) 182.71
Levered Free Cash Flow (M) 144.53

Stock Valuations

P/E 87.25
P/E Growth Ratio 0.01
P/BV 6.76
P/S 10.75
P/CF 43.50

Dividends & Splits

Dividend 1.280
Dividend Yield 0.01
Dividend Pay Date 2019-11-21
Ex-Dividend Date 2019-11-06
Forward Dividend 1.280
Last Split Date
Last Split Ratio 2
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.